EUVIMEDEUVIMED entdecken
Crossref

Marker‐Dependent Cleavage of RNA by Binary (split) DNAzyme (BiDz) and Binary DNA Machines (BiDM)

Mikhail V Dubovichenko, Daria D Nedorezova, Christina Patra, Valeria S Drozd, Vladimir S Andrianov, Anna I Ashmarova, Vivian O Nnanyereugo, Ahmed A Eldeeb, Dmitry M Kolpashchikov iD

ChemBioChem · 2024

DOI: 10.1002/cbic.202400665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Mikhail V Dubovichenko und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Nucleic Acid Nanotechnology, SCAMT Institute, ITMO University, 9 Lomonosova Str., St. Petersburg, 191002, Russian Federation. Hauptthemen laut MEDLINE: DNA, Catalytic, RNA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: project of ITMO University's priority 2030.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oligonucleotide gene therapy (OGT) can be used to suppress specific RNA in cells and thus has been explored for gene therapy. Despite extensive effort, there is no clinically significant OGT for treating cancer. Low efficiency of OGT is one of the problems. Earlier, we proposed to address this problem by suppressing the most vital genes in cancer cells e. g. housekeeping genes. To achieve specific activation of the OGT agents in cancer but not in normal cells, we designed a binary (split) DNAzyme (BiDz) activated by cancer‐related nucleic acid sequences. This work is devoted to BiDz optimization for efficient cleavage of structured RNA targets upon activation with a cancer marker‐related sequence. To achieve efficient binding of folded RNA, the BiDz was equipped with RNA binding/unwinding arms to produce ‘Binary DNA‐nanomachines’ (BiDM). It was demonstrated that BiDM can improve both the rate and selectivity of RNA cleavage in comparison with BiDz. For the best selectivity, single‐nucleotide variations should be recognized by the strand detached from the common DNA scaffold of BiDM. Further development of DNA nanotechnology‐inspired agents can advance OGT in treating cancer, viral infections, and genetic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, CatalyticRNAHumansRNA CleavageDNABiomarkers, Tumor

Stichwörter der Autor:innen

Binary (split) probesConditional activationDNAzymeGene therapy agentsHybridization selectivity

Substanzen

DNA, CatalyticRNADNABiomarkers, Tumor

Autor:innen und Institutionen

  • Laboratory of Nucleic Acid Nanotechnology, SCAMT Institute, ITMO University, 9 Lomonosova Str., St. Petersburg, 191002, Russian Federation.
  • Chemistry Department, University of Central Florida, Orlando, FL, 32816-2366, USA.
  • Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, 32816, USA.

ORCID-Profile: Dmitry M Kolpashchikov

Förderung

  • project of ITMO University's priority 2030

Zitieren

APA

Dubovichenko, M. V., Nedorezova, D. D., Patra, C., Drozd, V. S., Andrianov, V. S., Ashmarova, A. I., Nnanyereugo, V. O., Eldeeb, A. A., & Kolpashchikov, D. M. (2024). Marker‐Dependent Cleavage of RNA by Binary (split) DNAzyme (BiDz) and Binary DNA Machines (BiDM). ChemBioChem. https://doi.org/10.1002/cbic.202400665

Vancouver

Dubovichenko MV, Nedorezova DD, Patra C, Drozd VS, Andrianov VS, Ashmarova AI, et al. Marker‐Dependent Cleavage of RNA by Binary (split) DNAzyme (BiDz) and Binary DNA Machines (BiDM). ChemBioChem. 2024. doi:10.1002/cbic.202400665

BibTeX
@article{Dubovichenko2024,
  author = {Dubovichenko, Mikhail V and Nedorezova, Daria D and Patra, Christina and Drozd, Valeria S and Andrianov, Vladimir S and Ashmarova, Anna I and Nnanyereugo, Vivian O and Eldeeb, Ahmed A and Kolpashchikov, Dmitry M},
  title = {Marker‐Dependent Cleavage of RNA by Binary (split) DNAzyme (BiDz) and Binary DNA Machines (BiDM)},
  journal = {ChemBioChem},
  year = {2024},
  doi = {10.1002/cbic.202400665}
}
Kostenlos starten →